Riverbend Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$839K Sell
1,991
-619
-24% -$247K 0.38% 70
2026
Q2
$945K Buy
2,610
+184
+8% +$63K 0.47% 59
2026
Q1
$853K Buy
2,426
+106
+5% +$37.8K 0.49% 55
2025
Q4
$759K Buy
2,320
+147
+7% +$46.6K 0.47% 63
2025
Q3
$613K Buy
2,173
+62
+3% +$18K 0.43% 67
2025
Q2
$590K Buy
2,111
+112
+6% +$31.7K 0.45% 63
2025
Q1
$623K Buy
1,999
+221
+12% +$65.3K 0.56% 50
2024
Q4
$469K Buy
+1,778
New +$528K 0.42% 69

Other funds holding AMGN

Riverbend Wealth Management's AMGN Position: Q3 2026 in Review

Riverbend Wealth Management reduced its Amgen (AMGN) stake by 24% in Q3 2026, selling an estimated $247K and leaving 1,991 shares worth $839K. The position accounts for 0.38% of the portfolio, ranked #70.

Riverbend Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $945K in Q2 2026. 3,253 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Riverbend Wealth Management held 1,991 shares of Amgen worth $839K as of Q3 2026.
  • Riverbend Wealth Management sold 619 Amgen shares in Q3 2026, an estimated $247K.
  • Amgen made up 0.38% of Riverbend Wealth Management's portfolio in Q3 2026, its #70 holding.
  • Riverbend Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • Riverbend Wealth Management's Amgen position peaked at $945K in Q2 2026.
  • 3,253 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Riverbend Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.